1485135: NORGESTIMATE AND ETHINYL ESTRADI.
NORGESTIMATE AND ETHINYL ESTRADI. Key specifications include administration: ORAL, primary_container_content_quantity: 28.0 TABLETS, part_name_assigned_by_controlling_agency: ORTHO TRICYCLEN, 6 BLISTER CARDS, 168 TABLETS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-666-3685, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| total_primary_container_quantity | 6 |
| primary_container_content_quantity | 28.0 TABLETS |
| part_name_assigned_by_controlling_agency | ORTHO TRICYCLEN, 6 BLISTER CARDS, 168 TABLETS |
| NSN | 6505-01-666-3685 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 28.0 TABLETS |
| SPECIAL FEATURES | 7 TABLETS CONTAIN 0.18MG NORGESTIMATE AND 35MCG ETHINYL ESTRADIOL; 7 TABLETS CONTAIN 0.215MG NORGESTIMATE AND 35MCG ETHINYL ESTRADIOL; 7 TABLETS CONTAINS 0.25MG NORGESTIMATE AND 35MCG ETHINYL ESTRADIOL; 7 TABLETS CONTAIN INERT INGREDIENTS; 28 TABLETS PER CYCLE, 6 CYCLES; STORE AT 25 DEGREES C (77 F); EXCURSIONS PERMITTED TO 15-30 DEGREES C (59-86 F); PROTECT FROM LIGHT |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ORTHO TRICYCLEN, 6 BLISTER CARDS, 168 TABLETS |
| TOTAL PRIMARY CONTAINER QUANTITY | 6 |